Pillar Biosciences Receives Premarket Approval from FDA for its oncoReveal Dx Lung and Colon Cancer Assay
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
The TWYMEEG approval is supported by numerous preclinical and clinical studies, including the Phase 3 TIMES (Trials of IMeglimin for Efficacy and Safety) program managed jointly by both the companies
The company is exploring all legal options to challenge the award.
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
Subscribe To Our Newsletter & Stay Updated